Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ann M Bode

Showing results (151-160 of 339) with videos related to

Pageof 34
Sort By:
Cancer Research|September 19, 2007
Nuclear factor of activated T3 is a negative regulator of Ras-JNK1/2-AP-1 induced cell transformationKe Yao, Yong-Yeon Cho, H Robert Bergen, et al.
Cancer Prevention Research (Philadelphia, Pa.)|September 27, 2019
Scutellarin Suppresses Patient-Derived Xenograft Tumor Growth by Directly Targeting AKT in Esophageal Squamous Cell CarcinomaFeifei Liu, Xueyin Zu, Xiaomeng Xie, et al.
Research Square|January 9, 2026
CD70 drives cSCC growth by linking DNA damage response, inflammation, and tumor-stromal signalingTianshun Zhang, Qiushi Wang, Asad Khan, et al.
The Journal of Biological Chemistry|January 12, 2021
Structural basis for multifunctional roles of human Ints3 C-terminal domainJian Li, Xinli Ma, Surajit Banerjee, et al.
Plos One|June 18, 2015
Computational and Biochemical Discovery of RSK2 as a Novel Target for Epigallocatechin Gallate (EGCG)Hanyong Chen, Ke Yao, Xiaoyu Chang, et al.
Cancer Prevention Research (Philadelphia, Pa.)|July 14, 2011
Epigallocatechin-gallate suppresses tumorigenesis by directly targeting Pin1Darya V Urusova, Jung-Hyun Shim, Dong Joon Kim, et al.
The Journal of Biological Chemistry|August 9, 2008
(-)-Epigallocatechin gallate regulates CD3-mediated T cell receptor signaling in leukemia through the inhibition of ZAP-70 kinaseJung-Hyun Shim, Hong Seok Choi, Angelo Pugliese, et al.
Molecular Cancer Therapeutics|April 1, 2008
Effects of gefitinib (Iressa) on mammary cancers: preventive studies with varied dosages, combinations with vorozole or targretin, and biomarker changesRonald A Lubet, Eva Szabo, Konstantin Christov, et al.
Carcinogenesis|December 17, 2009
Myricetin inhibits UVB-induced angiogenesis by regulating PI-3 kinase in vivoSung Keun Jung, Ki Won Lee, Sanguine Byun, et al.
Cancer Prevention Research (Philadelphia, Pa.)|September 27, 2013
Concordant effects of aromatase inhibitors on gene expression in ER+ Rat and human mammary cancers and modulation of the proteins coded by these genesYan Lu, Ming You, Zara Ghazoui, et al.
Pageof 34

Showing results (151-160 of 339) with videos related to

Sort By:
Pageof 34
Cancer Research|September 19, 2007
Nuclear factor of activated T3 is a negative regulator of Ras-JNK1/2-AP-1 induced cell transformationKe Yao, Yong-Yeon Cho, H Robert Bergen, et al.
Cancer Prevention Research (Philadelphia, Pa.)|September 27, 2019
Scutellarin Suppresses Patient-Derived Xenograft Tumor Growth by Directly Targeting AKT in Esophageal Squamous Cell CarcinomaFeifei Liu, Xueyin Zu, Xiaomeng Xie, et al.
Research Square|January 9, 2026
CD70 drives cSCC growth by linking DNA damage response, inflammation, and tumor-stromal signalingTianshun Zhang, Qiushi Wang, Asad Khan, et al.
The Journal of Biological Chemistry|January 12, 2021
Structural basis for multifunctional roles of human Ints3 C-terminal domainJian Li, Xinli Ma, Surajit Banerjee, et al.
Plos One|June 18, 2015
Computational and Biochemical Discovery of RSK2 as a Novel Target for Epigallocatechin Gallate (EGCG)Hanyong Chen, Ke Yao, Xiaoyu Chang, et al.
Cancer Prevention Research (Philadelphia, Pa.)|July 14, 2011
Epigallocatechin-gallate suppresses tumorigenesis by directly targeting Pin1Darya V Urusova, Jung-Hyun Shim, Dong Joon Kim, et al.
The Journal of Biological Chemistry|August 9, 2008
(-)-Epigallocatechin gallate regulates CD3-mediated T cell receptor signaling in leukemia through the inhibition of ZAP-70 kinaseJung-Hyun Shim, Hong Seok Choi, Angelo Pugliese, et al.
Molecular Cancer Therapeutics|April 1, 2008
Effects of gefitinib (Iressa) on mammary cancers: preventive studies with varied dosages, combinations with vorozole or targretin, and biomarker changesRonald A Lubet, Eva Szabo, Konstantin Christov, et al.
Carcinogenesis|December 17, 2009
Myricetin inhibits UVB-induced angiogenesis by regulating PI-3 kinase in vivoSung Keun Jung, Ki Won Lee, Sanguine Byun, et al.
Cancer Prevention Research (Philadelphia, Pa.)|September 27, 2013
Concordant effects of aromatase inhibitors on gene expression in ER+ Rat and human mammary cancers and modulation of the proteins coded by these genesYan Lu, Ming You, Zara Ghazoui, et al.
Pageof 34